Bioscape

Shire Canada Inc. ("Shire Canada"), Shire Regenerative Medicine, Inc. ("Shire Regenerative Medicine") and Shire Human Genetic Therapies (Canada) Inc. ("Shire Human Genetic Therapies (Canada)") are wholly owned subsidiaries of Shire plc, a global specialty biopharmaceutical company that works closely with specialist physicians to develop and market medicines that improve the quality of life for patients, their families and caregivers.

Shire focuses on attention deficit hyperactivity disorder (ADHD), human genetic therapies, diabetic foot ulcers (DFUs) as well as gastrointestinal and renal diseases.